Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02841345
Other study ID # 38RC11.210
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2011
Est. completion date February 29, 2020

Study information

Verified date October 2018
Source University Hospital, Grenoble
Contact VANESSA ESPIN
Phone 4 76 76 68 13
Email VEspin@chu-grenoble.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the case of psychotic disorders such as bipolar disorder or schizophrenia, attention dysfunction contribute, according to the theories of neuroscience, the development of mood disorders following disturbances in the interaction-care emotion. In this context, the general objective of this research project is to refine our understanding of the similarities and distinctions between bipolar and schizophrenic patients in the basic emotional information processing. Specifically, these are: 1) to better understand what level of basic emotional information processing both conditions differ or are comparable and in what sense and 2) estimate, in both pathologies, the specific influence of the nature of the task of processing emotional information. To answer these questions, the investigators have developed a protocol to specifically target different information processing channels playing on the nature of the spatial frequency content of emotional natural scenes. To estimate in both pathologies, the specific influence of the nature of the task on emotional processing, 3 types of tasks are proposed: 1) a simple task perception and 2) -3) two tasks whose categorization one focused on the emotional feelings of the individual and the other on the tendency to action. Both tasks categorization should involve more specifically the ventromedial prefrontal cortex (CPFVM) and the dorsolateral prefrontal cortex (DLPFC) respectively. All patient data will be compared with data from healthy control participants.


Description:

Main goals This research project generally aims to refine our understanding of the similarities and distinctions between bipolar and schizophrenic patients in emotional information processing.

Specifically, these are:

1. better understand what level of emotional information processing both conditions differ or are comparable and in what direction

2. assess specifically in both pathologies, emotional regulation deficits through the realization of different cognitive tasks when processing emotional information.

To answer these questions, the investigators developed an original protocol imaging functional magnetic resonance (fMRI) to specifically target different information processing channels playing on the nature of the spatial frequency content of emotional natural scenes (see Methods). emotional regulation deficits in both disorders will be addressed in part through here 3 types of tasks: 1) a simple task perception and 2) -3) two tasks categorization of which centered on the emotional feelings of the individual (task affective) and the tendency to action (motivational task). Both tasks categorization should involve more specifically the Prefrontal Cortex-Ventro Median (CPFVM) and Lateral Prefrontal Cortex-Dorso (DLPFC), respectively, distinguishing between the two categories of patients. All patient data will be compared to healthy control participants.

This project will also allow us to improve our knowledge in bipolar and schizophrenic patients compared with control subjects, i) on the brain structures of networks involved in emotional information processing and emotional regulation, ii) functional relationships still unclear between neural structures involved in both processes and iii) the nature of the information passing through these networks.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date February 29, 2020
Est. primary completion date February 29, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility healthy volunteers

Inclusion criteria

- Informed Consent signed

- Medical examination conducted before research participation

- Age, sex and level of education paired with bipolar and schizophrenic patients)

- French Language and Culture

- normal or corrected vision and hearing to normal

- affiliate Obligation to social security

Exclusion criteria

- Topic included in an ongoing experiment

- contraindication to MRI (metal hardware or electronic incompatible with MRI examination, permanent glasses, braces, Claustrophobia, cardiac or neurological stimulator, Clip unsecured vascular nonmagnetic metal Eclat)

- Important Hearing Disorders and vision

- neurological pathologies or past or current neuropsychiatric

- Family history of psychiatric disorders

- Drug treatment may modulate brain activity: benzodiazepines, antidepressants, neuroleptics, etc.

- Alcohol Ingestion

- Pregnant women, women in labor, nursing mother

- All other categories of protected persons

bipolar patients

Inclusion criteria

- Informed Consent signed

- Review medical and psychiatric assessment and inclusion made before participation in research

- Membership or beneficiary of a social security scheme

- Age over 18 years

- Language and French culture

- study BAC level or equivalent

- normal or corrected vision and hearing to normal

- Inpatient and outpatient

- Diagnosis of bipolar disorder type I and II DSM-IV TR (A.P.A 1994)

- Clinical Stability (inter-Critical) for at least three months with scores of ladders MADRS <15 and YMRS <12.

- In case of anxiety symptoms, prescription Cyanemazine® or Hydroxyzine® be allowed, at low doses (<75 mg cyamemazine and hydroxyzyne).

Exclusion criteria

- Patient Refusal

- Diagnosis of bipolar disorder with rapid cycling and mixed episodes

- psychiatric pathology addictive disorder or schizophrenia / schizoaffective

- neurological pathologies or progressive neurosurgical

- Personal history of seizures

- Treatment with electroconvulsive therapy (ECT) in the 6 months preceding the assessment.

- Patients hospitalized under stress or under legal protection measure (guardianship, curatorship)

- Subject deprived of liberty by judicial or administrative decision

- Contraindications to the practice of MRI equipment or incompatible metal or electronic foreign body with MRI examination, permanent glasses, braces, Claustrophobia, cardiac or neurological stimulator, Clip unsecured vascular nonmagnetic metal Eclat)

- significant disorders of hearing and vision

- Alcohol Ingestion

- Pregnant women, women in labor, nursing mother

schizophrenic patients

Inclusion criteria

- Informed Consent signed

- Review medical and psychiatric assessment and inclusion made before participation in research

- Membership or beneficiary of a social security scheme

- Age over 18 years

- Language and French culture

- study BAC level or equivalent

- normal or corrected vision and hearing to normal

- Inpatient and outpatient

- diagnosis of schizophrenic disorders such deficit, paranoid and undifferentiated

- clinical stability for three months with PANSS scores <120 and no mood episode characterized (MADRS <15; YMRS <12)

Exclusion criteria

- Patient Refusal

- neurological pathologies or progressive neurosurgical

- psychiatric pathology addictive

- Patients hospitalized under stress or under legal protection measure (guardianship, curatorship)

- Subject deprived of liberty by judicial or administrative decision

- Contraindications to the practice of MRI equipment or incompatible metal or electronic foreign body with MRI examination, permanent glasses, braces, Claustrophobia, cardiac or neurological stimulator, Clip unsecured vascular nonmagnetic metal Eclat)

- significant disorders of hearing and vision

- Alcohol Ingestion

- Pregnant women, women in labor, nursing mother

Study Design


Related Conditions & MeSH terms


Intervention

Other:
behavioral and fMRI
The experience will include 3 sessions. Each session will consist of the presentation of a pseudo-random sequence of 24 black and white images of negative emotional natural scenes, 24 positive emotional situations and 24 neutral emotional situations. In the first session, participants will carry out an emotional assessment task: it will show at the end of each test his emotional feeling - pleasant, unpleasant or nothing - using a joystick. In a second session, the participant will perform a motor task decision: it will show at the end of each test the tendency to action he would handle the situation actually using 3 buttons également- approach withdrawal or neither one nor the other. In the third session, the participant will perform a simple visual perception task. To be comparable to the engine plane with the other sessions, a non-categorical motor task will be requested from participants.

Locations

Country Name City State
France GrenobleUniversityHospital La Tronche

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Psychometric evaluation PANSS - POSITIVE AND NEGATIVE SYNDROME SCALE Scale with 30 items 70 minutes
Primary Psychometric evaluation MADRS - Montgomery Asberg Depression Rating 15 minutes
Primary Psychometric evaluation YMRS - Young Mania Rating Scale 15 minutes
Primary Self-Questionnaire SHAPS - Snaith-Hamilton Pleasure Scale Starkstein STAI Y - State-Trait Anxiety Inventory AIM: "affect intensity measure" ALS: "affective lability scale" MATHYS Few hours
Primary Cognitive questionnaire CPT II - Conners' Continuous Performance Test II 15 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A